Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2022 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: technetium who wrote (233)	12/26/2022 11:49:53 AM
From: technetium	1 Recommendation Recommended By Lance Bredvold Respond to of 267

Time next year’s picks!! I browsed the web for FDA PDUFA dates and fdatracker.com popped up, and let me browse 2023 PDUFA dates for various companies with applications pending approval. When I tried looking at it again, it is behind a hazy paywall, and I can’t see the calendar. Oh well. I searched again on FDA PDUFA dates and this website popped up with the same information: rttnews.com Depending on how you word your web search for FDA PDUFA dates in 2023, you can find PR from various companies, some including “updated” PDUFA dates. During Covid, the FDA went all in on studying vaccines and tests for Covid, so many other things were pushed to the side, but I presume tht yt he FDA is catching up with the backlog. Another interesting website is the calendar for FDA Advisory Committee meetings, as this is where the trickier decisions get hashed out: fda.gov Plus, look at science news. There is interesting research going on, but it is not clear when it will move from a Demi to industry.

To: technetium who wrote (233)

12/30/2022 5:58:17 PM

From: technetium

Read Replies (1) | Respond to of 267

And at the wire …. it’s GENEGURU running away from the pack. A detailed report to follow.

GLYC came through at the end.

Now remember, you’ve got only a few more days to get your new portfolios in. Next year HAS to be better. Special offer, submitters of portfolios for the 2023 Contest can request a YTD breakdown of performance of the individual choices in 2022.

Thanks to everyone who participated in this contest.

Happy New Year!!

		Report Time Ranges
			From	To
		Recent	12/23/22	12/30/22
		YTD	12/31/2021	12/30/22
Index Performance
			Symbol	Recent	YTD
			^IXIC	-0.30%	-33.10%
			^NBI	-0.12%	-10.91%
			^SPSIBI	2.71%	-25.71%
Share Performance
Recent Change as % of Initial Price				YTD
Top 5		Bottom 5		Top 5		Bottom 5
GLYC	52.778%	SNGX	-29.27%	MACK	193.09%	GNCA	-99.99%
PDSB	42.346%	AMRS	-7.58%	CABA	144.06%	PLXP	-97.95%
MACK	27.877%	RVNC	-7.05%	WVE	122.93%	CLVS	-97.00%
OCUP	27.346%	IPIX	-6.00%	FENC	118.18%	ATHX	-96.27%
VKTX	20.652%	DYN	-5.55%	CBIO	113.07%	OTIC	-95.81%
Top Ten Portfolios
		Top 10 Portfolio YTD		YTD(Portfolio - SPSIBI)	Rec	Rec(Port. - SPSIBI)	Rec. Change Total Value
		GENEGURU	19.89%	45.61%	14.05%	11.345%	$14774.05
		DIEGOSAN	2.74%	28.45%	-0.27%	-2.975%	-$274.18
		MOPGCW	-2.01%	23.70%	8.99%	6.277%	$8079.59
		BMAZ001	-11.23%	14.48%	12.01%	9.304%	$9520.49
		TECHNETIUM	-18.35%	7.36%	1.96%	-0.751%	$1568.15
		BRENDAN_49	-20.04%	5.67%	4.34%	1.636%	$3329.50
		BIO-TITAN	-23.39%	2.32%	24.81%	22.097%	$15226.73
		RAJU_BIJLEE	-24.77%	0.94%	3.46%	0.748%	$2513.83
		ROCKY9	-25.80%	-0.09%	5.19%	2.482%	$3661.71
		TAMBORELLI	-25.96%	-0.24%	11.53%	8.819%	$7653.70
Average and Median Portfolio Performance
	Avg Recent	Avg YTD	Median Recent		Median YTD
	$3,795	-32.88%	RAJU_BIJLEE	$2,598	JFM WINTER	-32.22%
	6.16%	-32.88%	RAJU_BIJLEE	3.901%	JFM WINTER	-32.22%